|Full Name||deleted in liver cancer 1|
|Product Description||Rabbit Polyclonal antibody to DLC1 (deleted in liver cancer 1)|
|Background||This gene is deleted in the primary tumor of hepatocellular carcinoma. It maps to 8p22-p21.3, a region frequently deleted in solid tumors. It is suggested that this gene is a candidate tumor suppressor gene for human liver cancer, as well as for prostate, lung, colorectal, and breast cancers. Alternative splicing at this locus results in several transcript variants encoding different isoforms. [provided by RefSeq]|
|Synonyms||ARHGAP7 antibody, FLJ21120 antibody, HP antibody, STARD12 antibody, p122-RhoGAP antibody, DLC1 antibody, StAR-related lipid transfer (START) domain containing 12 antibody, rho-type GTPase-activating protein 7 antibody, deleted in liver cancer 1 variant 2 antibody, deleted in liver cancer 1 protein antibody, Rho-GTPase-activating protein 7 antibody, START domain-containing protein 12 antibody, rho GTPase-activating protein 7 antibody, deleted in liver cancer 1 antibody|
|Immunogen||Recombinant protein encompassing a sequence within the C-terminus region of human DLC1. The exact sequence is proprietary.|
|Species Reactivity||Human, Mouse|
|Predicted Cross Reactivity species Predicted cross-reactivity:|
Predicted cross-reactivity is based on sequence homology, with greater than 80% immunogen sequence identity considered positive.
Please note that we are only able to guarantee products to work in applications and species in which they have been tested.
|Rat, Dog, Bovine|
|Predict Reactivity Note||Rat (93%), Dog (97%), Bovine (96%)|